← Back to all trials
Completed
NCT06828705
Establish the First International Database on Semi-quantitative Values Obtained in Scintigraphy With Datscan® in Cadmium-Zinc-Telluride Camera
Conditions: Neurodegenerative Diseases
Sex: All
Ages: 18 Years – 99 Years
Healthy volunteers: No
Enrollment: 300
Sponsor: Central Hospital, Nancy, France
Location: CHRU NANCY Brabois, nuclear medicine department Vandœuvre-lès-Nancy
Summary
Datscan scintigraphy is a nuclear medicine examination allowing the diagnosis of neurodegenerative pathologies linked to damage to dopaminergic pathways, such as Parkinson's disease (essential for the differential diagnosis of essential tremor).
Eligibility Criteria
Inclusion Criteria:
* Adult patients who have undergone a Datscan scintigraphy on the VERITON camera in the nuclear medicine department of the Nancy University Hospital and who have an established clinical diagnosis, -Absence of neurodegenerative pathology or Parkinson's disease or Lewy body disease.
* The clinical diagnosis can only be established after two years of clinical follow-up.
Exclusion Criteria:
* Excluded from this research will be the patients opposed to the use of their data, minors, atypical Parkinsonian syndromes,
* patients who died before two years of clinical follow-up,
* patients who had their Datscan examination carried out on a camera other than the VERITON and - patients lost to follow-up.
Source: ClinicalTrials.gov (NCT06828705). StuddyBuddy aggregates publicly available trial information.